Therapix stock: buy or sell?
February 26th, 2020
Therapix Biosciences Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules.
Should I buy Therapix stock?Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Following a trading plan helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, Therapix stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Therapix stock a buy?
Banks and financial institutions publish stock ratings everyday.Unfortunately, we couldn't detect any rating for TRPX stock for the last month.
Therapix stock analysis
Shares of Therapix Biosciences plunged a dreadful -11.54% and closed at $0.46.
Therapix shares plunged -11.54% to $0.46 today.
Therapix Biosciences ended this week at $0.46 and collapsed a spooky -6.12%. By mid February TRPX rocketed a super good 11.76% in just one week.
Since mid March 2019, when TRPX stock price broke down the 40-weeks moving avarage line, it slid $-4.09 per share (-89.89%). Trading stocks that are below the 40-weeks (that is, 200-days) moving average mark is not recommended by many experts, as it indicates that the stock has not enough institutional support.
Therapix stock price history
Therapix IPO was on March 22nd, 2017 at $6.30 per share1. Since then, TRPX stock lost a -92.70%, with a yearly average of -46.40%.
1: Adjusted price after possible price splits or reverse-splits.
Therapix stock historical price chart
TRPX stock reached 52-week highs on March at $4.80, and all-time highs 2017-03-23 with a price of 10.95.
Therapix stock price targetPredicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. You should not follow the analysts' TRPX stock price predictions in the hope that they will be met as they may be wrong and not met. For the last month we have not found any price target for Therapix stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per Share, when Therapix Biosciences published its last earnings report, it . Unfortunately, reported EPS is not yet available in our database.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn , Therapix Biosciences annual turnover to million USD from marked in . , its income margin (compared to sales) to , that is million.
Quarterly financial resultsReported quarter earnings marked $-1.74 million with a profit margin of . Profit margin stayed stable a 0.00% compared to previous quarter when profit margin was inf%. When comparing sales to same quarter last year, Therapix Biosciences sales marked a tight move and stayed steady a nan%. Looking back to recent quarterly results, Therapix Biosciences posted 5 negative quarters in a row.
Therapix ownershipWhen you are planning to invest in a stock, it's worth to review its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Therapix, 9.73% of all outstanding shares are owned by its staff.
In case of Therapix Biosciences stock, 0.00% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for TRPX stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Therapix:
|Market cap||$3.3 M|
|Total shares||7.2 M|
|Float shares||4.1 M|
|- Institutional holdings (%)||0.0%|
|- Insider holdings (%)||9.7%|
|Shares in short selling||0.0%|
|Wednesday, February 26th, 2020|
|Day range||$0.45 - $0.53|
|Average true range||$0.07|
|50d mov avg||$0.76|
|100d mov avg||$1.38|
|200d mov avg||$2.01|
Therapix performanceTo measure stock performance is always good to benchmark with competitors or related stocks. In the following table, we compare Therapix Biosciences to :